At the invitation of the European Medicines Agency (EMA), the Institute for Medicines and Medical Devices (CInMED) has become one of the partners of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance, ENCePP. ENCePP network brings together research centres, institutions and organizations that collect data from the field of health, with the aim of better monitoring of benefit-risk ratios in the use of medicines at the EU level.  

ENCePP network combine capacities and resources in the field of pharmacoepidemiology and pharmacovigilance throughout Europe and provides a platform for the cooperation of public and private institutions and organizations. This cooperation enables the implementation of high-quality, multicentre, independent non-interventional studies, as well as the development and maintenance of methodological standards and management principles for research in the field of pharmacovigilance and pharmacoepidemiology. The ENCePP network is also a network of excellence in pharmacoepidemiology that may be used in public health emergencies.

Since 2007 EMA has been coordinating the ENCePP network and the invitation for cooperation was sent to CInMED within the framework of support to the EU candidate countries. As an ENCePP partner, CInMED will get the opportunity to use joint expertise, as well as to participate in plenary meetings and working groups, which is very significant for the improvement of national capacities in this area. More information about the activities of the ENCePP network and its partners is available at https://encepp.europa.eu/index_en.